<DOC>
	<DOC>NCT01382420</DOC>
	<brief_summary>Objective: To determine the metabolic effects of the adrenalectomy in subclinical Cushing's syndrome of adrenal incidentaloma. Methods: 234 subclinical cushing syndrome and adrenal incidentaloma will be randomly assigned into two groups(e.g adrenalectomy group and conservative treatment group).</brief_summary>
	<brief_title>Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Adrenocortical Adenoma</mesh_term>
	<mesh_term>Adrenal Gland Neoplasms</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>patients with both unilateral adrenal incidentaloma and hypercortisolism definition of hypercortisolism overnight dexamethasone suppression test, serum cortisol&gt;1.8ug/dL 24hr urine cortisol &gt; upper reference limit patients who took medication influencing cortisol secretion patients with definite clinical feature of cushing syndrome moon face abdominal striae skin or proximal muscle atrophy metabolic syndrome, hyperthyroidism, hyperparathyroidism, chronic renal failure, rheumatic disease, hematologic disease patients who took following medication insulin oral hypoglycemic agent thyroid hormone antihyperlipidemic drug sex hormone patients who taking steroid hormone or who took steroid hormone more than 2 weeks within 1 year psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>subclinical cushing syndrome</keyword>
	<keyword>hypercortisolism</keyword>
	<keyword>adrenal incidentaloma</keyword>
	<keyword>adrenalectomy</keyword>
</DOC>